What is she best known for?
The fields of study she is best known for:
Ruth Arnon focuses on Immunology, Encephalomyelitis, Antigen, Epitope and Molecular biology.
Her Immunology study frequently involves adjacent topics like Transplantation.
Her Encephalomyelitis research incorporates elements of Copolymer I, Polyclonal B cell response, Pharmacology and Glutamic acid.
Her studies in Epitope integrate themes in fields like Virus, Virology, Cellular immunity and Microbiology.
She has researched Molecular biology in several fields, including Antigen-presenting cell, Antiserum, Antibody, Biochemistry and Myelin basic protein.
Her study in the field of Monoclonal antibody is also linked to topics like Conjugate.
Her most cited work include:
- A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis (433 citations)
- Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. (389 citations)
- Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis (275 citations)
What are the main themes of her work throughout her whole career to date?
Ruth Arnon mainly focuses on Immunology, Biochemistry, Antibody, Antigen and Molecular biology.
All of her Immunology and Encephalomyelitis, Multiple sclerosis, Immune system, Glatiramer acetate and Experimental autoimmune encephalomyelitis investigations are sub-components of the entire Immunology study.
In her study, Trematoda is inextricably linked to Schistosoma mansoni, which falls within the broad field of Biochemistry.
Her biological study spans a wide range of topics, including Cytotoxic T cell, In vivo, Cancer research and Drug.
Epitope is the focus of her Antigen research.
Ruth Arnon focuses mostly in the field of Molecular biology, narrowing it down to topics relating to Myelin basic protein and, in certain cases, T cell and Major histocompatibility complex.
She most often published in these fields:
- Immunology (29.49%)
- Biochemistry (27.18%)
- Antibody (25.90%)
What were the highlights of her more recent work (between 2004-2021)?
- Immunology (29.49%)
- Glatiramer acetate (8.72%)
- Multiple sclerosis (11.79%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Immunology, Glatiramer acetate, Multiple sclerosis, Experimental autoimmune encephalomyelitis and Neuroprotection.
Her Immunology study often links to related topics such as Brain-derived neurotrophic factor.
Her Experimental autoimmune encephalomyelitis research includes elements of Encephalomyelitis and Myelin.
Her studies deal with areas such as Virology, Epitope, Antigen, Adjuvant and Antigenic drift as well as Immune system.
The Virology study combines topics in areas such as Polynucleotide, Antibody and Nucleic acid.
In her research, Microbiology is intimately related to Virus, which falls under the overarching field of Antigen.
Between 2004 and 2021, her most popular works were:
- The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice (185 citations)
- Neurogenesis and Neuroprotection Induced by Peripheral Immunomodulatory Treatment of Experimental Autoimmune Encephalomyelitis (128 citations)
- Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis. (93 citations)
In her most recent research, the most cited papers focused on:
Her primary areas of investigation include Immunology, Glatiramer acetate, Multiple sclerosis, Experimental autoimmune encephalomyelitis and Neuroprotection.
Her Immunology study frequently draws connections between adjacent fields such as Recombinant DNA.
Her Glatiramer acetate research integrates issues from Colitis and Inflammatory bowel disease.
Her work focuses on many connections between Multiple sclerosis and other disciplines, such as Neurogenesis, that overlap with her field of interest in Transgene, Genetically modified mouse and Myelin oligodendrocyte glycoprotein.
Her research in Experimental autoimmune encephalomyelitis intersects with topics in Brain-derived neurotrophic factor and Encephalomyelitis.
As part of one scientific family, Ruth Arnon deals mainly with the area of Pharmacology, narrowing it down to issues related to the Immune system, and often Antigen, Epitope mapping and Microbiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
